GlassScriptPhysician profile
Mandy L Lasinsky
NPI 1689301780
$2,118.78
in general payments reported to CMS, 2019-2025
15 companies · $519 in 2025
The $519 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $648 · 2023: $367 · 2024: $586 · 2025: $519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,471.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $512.53 | 2022-2025 | Watchman Flx, Watchman |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $290.07 | 2022-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $250.30 | 2022-2025 | Breztri, Farxiga |
| Teva Pharmaceuticals USA, INC. | $244.87 | 2022-2024 | Uzedy, Austedo |
| Inari Medical, INC. | $188.52 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amgen INC. | $129.76 | 2022-2024 | Repatha |
| Novo Nordisk INC | $112.50 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $78.81 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $69.19 | 2025 | |
| Alexion Pharmaceuticals, INC. | $64.38 | 2024 | |
| Stryker Corporation | $49.17 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Mannkind Corporation | $43.94 | 2022 | |
| Abbvie INC. | $39.53 | 2025 | |
| Corcept Therapeutics | $30.52 | 2024 | Korlym |
| Novartis Pharmaceuticals Corporation | $14.69 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mandy Lasinsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.